Dealing with uncertainty in drug safety: lessons for the future from sertindole
- 15 May 2003
- journal article
- editorial
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 12 (4) , 283-287
- https://doi.org/10.1002/pds.849
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Biases affecting the proportional reporting ratio (PRR) in spontaneous reports pharmacovigilance databases: the example of sertindolePharmacoepidemiology and Drug Safety, 2003
- The Lancet's policy on conflicts of interestThe Lancet, 2003
- Making progress with competing interestsBMJ, 2002
- Arrhythmias and sudden death in patients taking antipsychotic drugsBMJ, 2002
- A memorable patient: Straight from the patient's mouthBMJ, 2002
- A model for the future conduct of pharmacovigilancePharmacoepidemiology and Drug Safety, 2002
- Epidemiology on trialThe Lancet, 2002
- A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactionsPharmacoepidemiology and Drug Safety, 2002
- Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reportsPharmacoepidemiology and Drug Safety, 2001
- Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysisContraception, 2001